Polymyalgia Rheumatica

Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor
Karmela Kim Chan, Anne R Bass

Annals of the Rheumatic Diseases Jul 2019, 78 (7) e70; DOI: 10.1136/annrheumdis-2018-213672
Response to: ’Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass
Marie Kostine, Léa Dousset, Thierry Schaeverbeke

Annals of the Rheumatic Diseases Jul 2019, 78 (7) e71; DOI: 10.1136/annrheumdis-2018-213682
Incidence of inflammatory polyarthritis in polymyalgia rheumatica: a population-based cohort study
Max Yates, Jalpa Kotecha, Richard A Watts, Robert Luben, Kay-Tee Khaw, Alexander J MacGregor

Annals of the Rheumatic Diseases May 2019, 78 (5) 704-705; DOI: 10.1136/annrheumdis-2018-214386
Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study
Richard James Partington, Sara Muller, Toby Helliwell, Christian D Mallen, Alyshah Abdul Sultan

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1750-1756; DOI: 10.1136/annrheumdis-2018-213883
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis
Lucie Descamps, Louis Olagne, Charles Merlin, Florent Cachin, Martin Soubrier, Sylvain Mathieu

Annals of the Rheumatic Diseases Nov 2018, 77 (11) e81; DOI: 10.1136/annrheumdis-2017-212660
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan et al
Verena Schönau, Georg Schett

Annals of the Rheumatic Diseases Nov 2018, 77 (11) e83; DOI: 10.1136/annrheumdis-2017-212785
Jacques FORESTIER, a visionary of the clinical epidemiology in rheumatology
Maxime Dougados

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1097-1098; DOI: 10.1136/annrheumdis-2018-213560
Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events
David S Pisetsky

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 795-796; DOI: 10.1136/annrheumdis-2018-213561
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study
Marie Kostine, Léa Rouxel, Thomas Barnetche, Rémi Veillon, Florent Martin, Caroline Dutriaux, Léa Dousset, Anne Pham-Ledard, Sorilla Prey, Marie Beylot-Barry, Amaury Daste, Marine Gross-Goupil, Julie Lallier, Alain Ravaud, Edouard Forcade, Bernard Bannwarth, Marie-Elise Truchetet, Christophe Richez, Nadia Mehsen, Thierry Schaeverbeke

Annals of the Rheumatic Diseases Mar 2018, 77 (3) 393-398; DOI: 10.1136/annrheumdis-2017-212257
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment
Rakiba Belkhir, Sébastien Le Burel, Laetitia Dunogeant, Aurélien Marabelle, Antoine Hollebecque, Benjamin Besse, Alexandra Leary, Anne-Laure Voisin, Clémence Pontoizeau, Laetitia Coutte, Edouard Pertuiset, Gaël Mouterde, Olivier Fain, Olivier Lambotte, Xavier Mariette

Annals of the Rheumatic Diseases Oct 2017, 76 (10) 1747-1750; DOI: 10.1136/annrheumdis-2017-211216

Main menu

Polymyalgia Rheumatica

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Polymyalgia Rheumatica

Pages